[230 Pages Report] Growing prevalence of acute kidney injury as well as increasing early diagnosis with subsequent increasing treatment seeking rate are the prime drivers of the global acute kidney injury treatment market. Treatment such as dialysis therapies has resulted in better management of acute kidney injury, and has helped reduce the risk of various kidney-related diseases.

Various organisations are involved in acute kidney injury disease surveillance. In 2021, China's central government issued the 13th Five Year National Science and Technology Innovation Plan, which aims to create a national platform to share biomedical big data, develop technologies for precision medicine, and integrate them into a multilevel knowledge database, leading the healthcare treatment market to new growth avenues.

The global acute kidney injury treatment market is projected to exhibit a noteworthy 8% CAGR over the forecast period (2022-2029).

"Increasing prevalence of acute kidney injury across the world and increasing number of dialysis centers are prominent factors augmenting the growth prospects of the global acute kidney injury treatment market."

Key Takeaways of Acute Kidney Injury Treatment Market Study

• Owing to increasing acute kidney injury prevalence, number of dialysis centers, and efficient treatment method, the dialysis segment is expected to be a significant revenue generator.
• The intermittent hemodialysis segment, under product, in the acute kidney injury treatment market, is expected to be a prominent segment, as results provided by this treatment are more efficient as compared to other dialysis methods.
• The pre-renal injury segment is anticipated to dominate the acute kidney injury treatment market, as pre-renal injury is more prevalent in patients with acute kidney injury.
• North America is expected to dominate the global acute kidney injury treatment market in terms of revenue, owing to the growing adoption of advanced treatments over conventional methods. East Asia is expected to offer lucrative opportunities for the acute kidney injury treatment market during the forecast period.

To remain ahead of your competitors, request for a sample - https://www.futuremarketinsights.com/reports/sample/rep-gb-14403

Advanced Technology & Product Launches - Key Strategies Followed by Manufacturers

Advancements in diagnostic technology and more product availability in order to streamline their product offerings in respective regions with diverse product portfolios are being followed by players in the acute kidney injury treatment market. For instance, in January, 2022, Fresenius Medical Care launched the 4008A dialysis machine to improve accessibility to life-sustaining dialysis treatment.

More Valuable Insights on Acute Kidney Injury Treatment Market

Future Market Insights brings a comprehensive research report on forecast revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global acute kidney injury treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readers.

The study provide compelling insights on the acute kidney injury treatment market on the basis of product (dialysis and drug therapy), injury (pre-renal injury, intrinsic renal injury, and post-renal injury), and distribution channel (hospitals, ambulatory surgical centers, and others), across seven major regions.

Acute Kidney Injury Treatment Market By Category Product :

• Dialysis
  • Intermittent Hemodialysis
  • Continuous Renal Replacement Therapy (CRRT)
  • Sustained Low Efficiency Dialysis (SLED)

• Drug Therapy
  • Antibiotics
  • Diuretics
  • Immunosuppressive Agents

Injury :

• Pre-renal Injury
• Intrinsic Renal Injury
• Post-renal Injury

Distribution Channel :

• Hospitals
• Ambulatory Surgical Centers
• Others

Ask from Market Research Expert - https://www.futuremarketinsights.com/ask-question/rep-gb-14403

Region :

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

More Trending Reports by Future Market Research :

Continuous Renal Replacement Therapy Market : The continuous renal replacement therapy market is valued at US$ 1 Billion in 2021. The market is likely to grow at a CAGR of 7.7% through 2027, reaching US$ 1.68 Billion.

Gamma Knife Market : The Gamma Knife Market is expected to surpass US$ 287.3 Mn in 2021, according to Future Market Insights (FMI) analysis. Exhibiting a CAGR of 5.90% between 2021 and 2031, the market is expected to reach US$ 507.0 Mn by 2031.

Cancer Tissue Diagnostics Market : The global cancer tissue diagnostics market is expected to reach a market valuation of US$ 5.3 Billion by the year 2022, accelerating with a moderate CAGR of 6.6% by 2022-2032.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights,

Unit No: 1602-006,

Jumeirah Bay 2,

Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers,

Dubai,

United Arab Emirates

For Sales Enquiries: [email protected]

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

The post Acute Kidney Injury Treatment Market is expected to witness staggering growth, registering 8.2% CAGR from (2022-2029) appeared first on Future Market Insights.

Original Source of the original story >> Acute Kidney Injury Treatment Market is expected to witness staggering growth, registering 8.2% CAGR from (2022-2029)

This content is published on behalf of the above source. Please contact them directly for any concern related to the above.

This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.